Àü³²´ëÇб³º´¿ø 2023 ¿µ»óÀÇÇÐ ½ÉÆ÷Áö¾ö : 2023-06-25
±³À°ÀÏÀÚ : 2023-06-25
±³À°Àå¼Ò : Àü³²ÀÇ´ë ´öÀçȦ
±³À°ÁÖÁ¦ : 2023 ¿µ»óÀÇÇÐ ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : Àü³²´ëÇб³º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¿µ»óÀÇÇаú
´ã´çÀÚ : ±è°¡¿µ
¿¬¶ôó : 062-220-5752
À̸ÞÀÏ : cnuhrad1@gmail.com
±³À°Á¾·ù : ¿µ»óÀÇÇаú
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ±¤ÁÖ±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 40,000¿ø
ºñ°í »çÀüµî·Ï(Àü¹®ÀÇ : 30,000¿ø / Àü°øÀÇ 10,000¿ø)ÇöÀåµî·Ï(Àü¹®ÀÇ : 40,000¿ø / Àü°øÀÇ 20,000¿ø)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06¿ù 25ÀÏ ´öÀçȦ 09:00~09:30 CT cardiovascular abnormality in oncology patients Á¤¿ø±â(ȼøÀü³²´ëÇб³º´¿ø)
±³À°½Ã°£ 06¿ù 25ÀÏ ´öÀçȦ 09:30~10:00 CT Prognostic factors of lung cancer patients ÃÖÇý¿ø(Áß¾Ó´ëÇб³º´¿ø)
±³À°½Ã°£ 06¿ù 25ÀÏ ´öÀçȦ 10:00~10:30 The role of chest biopsy in oncology center ¹Úº´°Ç(Ä¥°î°æºÏ´ëÇб³º´¿ø)
Åä·Ð 06¿ù 25ÀÏ ´öÀçȦ 10:30~10:40 Q & A ( )
ÈÞ½Ä 06¿ù 25ÀÏ 10:40~10:50 Break time ( )
±³À°½Ã°£ 06¿ù 25ÀÏ ´öÀçȦ 10:50~11:20 Pneumonia in immunocompromised patients Á¤Á¤ÀÓ(°¡Å縯¼º¸ðº´¿ø)
±³À°½Ã°£ 06¿ù 25ÀÏ ´öÀçȦ 11:20~11:50 Mycobacterial and parasitic infection ¹Ú¼ÒÇö(¼¿ï¾Æ»êº´¿ø)
Åä·Ð 06¿ù 25ÀÏ ´öÀçȦ 11:50~12:00 Q & A ( )
ÈÞ½Ä 06¿ù 25ÀÏ 12:00~13:00 Lunch ( )
±³À°½Ã°£ 06¿ù 25ÀÏ ´öÀçȦ 13:00~13:30 Calcium scoring CT: current guideline & clinical implication ÃÖ»óÀÏ(ºÐ´ç¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 06¿ù 25ÀÏ ´öÀçȦ 13:30~14:00 Interpretation of coronary CT angiography: Updated in 2022 CAD-RADS 2.0 ±è¼º¸ñ(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 06¿ù 25ÀÏ ´öÀçȦ 14:00~14:30 Coronary artery variants and anomalies ÀÌÁ¾Àº(Àü³²´ëÇб³º´¿ø)
Åä·Ð 06¿ù 25ÀÏ ´öÀçȦ 14:30~14:40 Q & A ( )
ÈÞ½Ä 06¿ù 25ÀÏ 14:40~14:50 Break time ( )
±³À°½Ã°£ 06¿ù 25ÀÏ ´öÀçȦ 14:50~15:20 Malignancy risk of amorphous microcalcifications ÀÌÈ¿Àç(Àü³²´ëÇб³º´¿ø)
±³À°½Ã°£ 06¿ù 25ÀÏ ´öÀçȦ 15:20~15:50 BI-RADS 3 for US and MRI ÀÓÈ¿¼ø(ȼøÀü³²´ëÇб³º´¿ø)
±³À°½Ã°£ 06¿ù 25ÀÏ ´öÀçȦ 15:50~16:20 Pearls and pitfalls of ABUS interpretation ÃÖÀºÁ¤(ÀüºÏ´ëÇб³º´¿ø)
Åä·Ð 06¿ù 25ÀÏ ´öÀçȦ 16:20~16:30 Q & A ( )